The Ovarian Cancer Research Fund Alliance has honored Jeff Boyd, chair of the Department of Human and Molecular Genetics and professor of obstetrics and gynecology, as the winner of its 2016 Rosalind Franklin Excellence in Ovarian Cancer Research Award.
Boyd is a national and international expert in the study of molecular genetics of women’s cancers. One of his key areas of research and expertise is genomic medicine, which uses DNA from a patient’s tumor to identify gene mutations and help doctors determine how to best treat that patient’s cancer.
The Alliance, created by the recent merger of the Ovarian Cancer National Alliance and the Ovarian Cancer Research Fund, is a national organization that advances the interests of women with ovarian cancer by connecting survivors, women at risk, caregivers and health providers with the information and resources they need. It also lobbies lawmakers and government agencies to ensure that ovarian cancer is a priority in Washington, D.C., and throughout the country.
The award is named for molecular biologist Dr. Rosalind Elsie Franklin, who played a vital role in discovering the structure of DNA. Franklin died of ovarian cancer in 1958 at the age of 37.
Boyd, who is also director of Translational Research and Genomic Medicine at Miami Cancer Institute, received the award at the 2016 Ovarian Cancer National Conference in Washington, D.C., on Sat., July 9.